Literature DB >> 12207871

Single dose pharmacokinetics and bioavailability of glucosamine in the rat.

Ali Aghazadeh-Habashi1, Saeed Sattari, Franco Pasutto, Fakhreddin Jamali.   

Abstract

PURPOSE: To study pharmacokinetics of glucosamine following various routes of administration of the hydrochloride salt to rats and locate the site of its first-pass metabolism.
METHODS: Rat were cannulated in the jugular vein and single intravenous, oral and intra peritoneal doses of 350 mg/kg were administered. Serial blood samples were collected and plasma glucosamine concentrations were determined using HPLC.
RESULTS: After intravenous administration, the apparent terminal half-life (1.09 +/- 0.98 h), apparent steady state volume of distribution (2.1 +/- 1.1 L.kg(-1)) and total body clearance (2.61 +/- 0.81 L.kg(-1.h-1)) were calculated. The peak plasma concentration, after oral administration, occurred approximately 30 min post-dose and the absolute bioavailability was 0.19. Glucosamine was completely bioavailable after intraperitoneal administration.
CONCLUSION: Orally administered glucosamine is rapidly absorbed, highly distributed and efficiently cleared. The gut rather than liver is mainly responsible for the first pass metabolism since reduced bioavailability is observed after oral but not intraperitoneal doses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207871

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  17 in total

1.  Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles.

Authors:  Samantha Coulson; Henry Butt; Phillip Vecchio; Helen Gramotnev; Luis Vitetta
Journal:  Inflammopharmacology       Date:  2012-07-22       Impact factor: 4.473

2.  Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis.

Authors:  A R Shikhman; D Amiel; D D'Lima; S-B Hwang; C Hu; A Xu; S Hashimoto; K Kobayashi; T Sasho; M K Lotz
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

3.  Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.

Authors:  B A Biggee; C M Blinn; T E McAlindon; M Nuite; J E Silbert
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

4.  Effects of [3H]glucosamine concentration on [3H]chondroitin sulphate formation by cultured chondrocytes.

Authors:  Paula J Mroz; Jeremiah E Silbert
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

5.  Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.

Authors:  Dongqi Xing; Wenguang Feng; Laszlo G Nöt; Andrew P Miller; Yun Zhang; Yiu-Fai Chen; Erum Majid-Hassan; John C Chatham; Suzanne Oparil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-09       Impact factor: 4.733

6.  Dietary glucosamine under question.

Authors:  Jeremiah E Silbert
Journal:  Glycobiology       Date:  2009-03-02       Impact factor: 4.313

7.  Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses.

Authors:  Robert Kisilevsky; Walter A Szarek; John B Ancsin; Elena Elimova; Sandra Marone; Shridhar Bhat; Ali Berkin
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

8.  Metabolomic analyses of blood plasma after oral administration of D-glucosamine hydrochloride to dogs.

Authors:  Tomohiro Osaki; Kazuo Azuma; Seiji Kurozumi; Yoshimori Takamori; Takeshi Tsuka; Tomohiro Imagawa; Yoshiharu Okamoto; Saburo Minami
Journal:  Mar Drugs       Date:  2012-08-22       Impact factor: 6.085

9.  Impact of Glucosamine Supplementation on Gut Health.

Authors:  Jessica M Moon; Peter Finnegan; Richard A Stecker; Hanna Lee; Kayla M Ratliff; Ralf Jäger; Martin Purpura; Carolyn M Slupsky; Maria L Marco; Craig J Wissent; Jason Theodosakis; Chad M Kerksick
Journal:  Nutrients       Date:  2021-06-24       Impact factor: 5.717

10.  Amelioration of collagen-induced arthritis in female dark agouti rats by glucosamine treatment.

Authors:  Nagaraja Haleagrahara; Dulanthi Tudawe; Srikumar Chakravarthi; Ammu Kutty Radhakrishnan
Journal:  ISRN Pharmacol       Date:  2013-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.